SANGINITA2025-04-012025-06-30SANGINITA2025-04-012025-06-30in-capmkt:OtherExpenses1MemberSANGINITA2025-04-012025-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1SANGINITA2025-04-012025-06-30ItemsThatWillBeReclassifiedToProfitAndLoss1SANGINITA2025-04-012025-06-30AuditorDomain1iso4217:INRiso4217:INRxbrli:shares000000SANGINITANOTLISTEDINE753W01010Sanginita Chemicals LimitedMain BoardEquity2025-04-012026-03-312025-07-112025-07-01INRLakhsQuarterlyFirst quarterSingle segmentChemicals2025-07-1115:00:002025-07-1116:15:00Declaration of unmodified opinionfalsefalseNot Applicable2025-04-012025-06-30UnauditedStandalone4591040003736000462840000226914000219398000-187200028910005304000542400037760004618350001005000010050000-72000-72000010770000000107700001077000259016000100.040.04000.040.041 The above results have been reviewed by the Audit Committee and taken on record by the Board of Directors at their meeting held on 11th July, 2025 and the same have been subjected to limited review by the Statutory Auditors of the Company. <BR> <BR> 2. The figures for the corresponding previous period have been restated, regrouped wherever necessary, to make them comparable. <BR> <BR> 3. In line with Ind AS - 108 Operating Segments, the operations of the company fall under chemical business which is considered to be the only reportable business segment. <BR> Other Expenses3776000Amount of Items that will not be reclassified to Profit and Loss000Amount of Items that will be reclassified to Profit and Loss0000UnauditedtrueB K Chavda & Co.true2027-05-31